Medistim ASA reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was NOK 491.94 million compared to NOK 421.98 million a year ago. Revenue was NOK 491.94 million compared to NOK 427.28 million a year ago.

Net income was NOK 113.97 million compared to NOK 90.9 million a year ago. Basic earnings per share from continuing operations was NOK 6.25 compared to NOK 4.99 a year ago. Diluted earnings per share from continuing operations was NOK 6.24 compared to NOK 4.98 a year ago.